共 116 条
- [1] Schlumberger M.(2008)New therapeutic approaches to treat medullary thyroid carcinoma Nat Clin Pract Endocrinol Metab 4 22-32
- [2] Carlomagno F.(2008)RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series Clin Endocrinol (Oxf) 69 418-425
- [3] Baudin E.(2011)Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification Eur J Endocrinol 164 971-976
- [4] Bidart J.M.(2008)Prognostic significance of somatic J Clin Endocrinol Metab 93 682-687
- [5] Santoro M.(2011) oncogene mutations in sporadic medullary thyroid cancer: A 10-year follow-up study J Clin Endocrinol Metab 96 E863-E868
- [6] Fugazzola L.(2011)High prevalence of J Clin Oncol 29 2660-2666
- [7] Muzza M.(2006) mutations in RET-negative sporadic medullary thyroid carcinomas Cancer 107 2134-2142
- [8] Mian C.(2012)Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer Semin Radiat Oncol 22 254-262
- [9] Mian C.(1996)Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases Thyroid 6 305-310
- [10] Pennelli G.(1996)The role of external beam radiation and targeted therapy in thyroid cancer Eur J Surg Oncol 22 588-591